685 related articles for article (PubMed ID: 32503256)
21. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
Jin Y; Wang M; Hu H; Huang Q; Chen Y; Wang G
Int J Biol Macromol; 2018 Oct; 117():445-453. PubMed ID: 29852230
[TBL] [Abstract][Full Text] [Related]
22. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
23. Cancer stem cells in colorectal cancer and the association with chemotherapy resistance.
Lei X; He Q; Li Z; Zou Q; Xu P; Yu H; Ding Y; Zhu W
Med Oncol; 2021 Mar; 38(4):43. PubMed ID: 33738588
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle heterogeneity and plasticity of colorectal cancer stem cells.
Higa T; Nakayama KI
Cancer Sci; 2024 May; 115(5):1370-1377. PubMed ID: 38413370
[TBL] [Abstract][Full Text] [Related]
25. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.
Mangiapane LR; Nicotra A; Turdo A; Gaggianesi M; Bianca P; Di Franco S; Sardina DS; Veschi V; Signore M; Beyes S; Fagnocchi L; Fiori ME; Bongiorno MR; Lo Iacono M; Pillitteri I; Ganduscio G; Gulotta G; Medema JP; Zippo A; Todaro M; De Maria R; Stassi G
Gut; 2022 Jan; 71(1):119-128. PubMed ID: 33436496
[TBL] [Abstract][Full Text] [Related]
26. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
27. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
Yu Y; Nangia-Makker P; Farhana L; G Rajendra S; Levi E; Majumdar AP
Mol Cancer; 2015 May; 14():98. PubMed ID: 25928322
[TBL] [Abstract][Full Text] [Related]
28. [Research progression in colorectal cancer stem cells].
Wu TY; Cui L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):297-300. PubMed ID: 23536355
[TBL] [Abstract][Full Text] [Related]
29. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
[TBL] [Abstract][Full Text] [Related]
30. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
[TBL] [Abstract][Full Text] [Related]
31. Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells.
Shirmohamadi M; Eghbali E; Najjary S; Mokhtarzadeh A; Kojabad AB; Hajiasgharzadeh K; Lotfinezhad P; Baradaran B
J Cell Physiol; 2020 Feb; 235(2):776-789. PubMed ID: 31264216
[TBL] [Abstract][Full Text] [Related]
32. Novel therapeutic strategies for targeting liver cancer stem cells.
Oishi N; Wang XW
Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
[TBL] [Abstract][Full Text] [Related]
33. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.
Wei F; Zhang T; Deng SC; Wei JC; Yang P; Wang Q; Chen ZP; Li WL; Chen HC; Hu H; Cao J
Cancer Lett; 2019 May; 450():1-13. PubMed ID: 30776481
[TBL] [Abstract][Full Text] [Related]
34. LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer.
Nie X; Liu H; Ye W; Wei X; Fan L; Ma H; Li L; Xue W; Qi W; Wang YD; Chen WD
J Cell Mol Med; 2022 Feb; 26(4):1095-1112. PubMed ID: 34997691
[TBL] [Abstract][Full Text] [Related]
35. Microarray Analysis of Gene Expression Involved in Butyrate-Resistant Colorectal Carcinoma HCT116 Cells.
Khonthun C; Saikachain N; Popluechai S; Kespechara K; Hiranyakas A; Srikummool M; Surangkul D
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1739-1746. PubMed ID: 32592372
[TBL] [Abstract][Full Text] [Related]
36. Regorafenib suppresses colon tumorigenesis and the generation of drug resistant cancer stem-like cells via modulation of miR-34a associated signaling.
Cai MH; Xu XG; Yan SL; Sun Z; Ying Y; Wang BK; Tu YX
J Exp Clin Cancer Res; 2018 Jul; 37(1):151. PubMed ID: 30005681
[TBL] [Abstract][Full Text] [Related]
37. Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance.
Ebrahimi N; Afshinpour M; Fakhr SS; Kalkhoran PG; Shadman-Manesh V; Adelian S; Beiranvand S; Rezaei-Tazangi F; Khorram R; Hamblin MR; Aref AR
Crit Rev Oncol Hematol; 2023 Feb; 182():103920. PubMed ID: 36702423
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X
Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357
[TBL] [Abstract][Full Text] [Related]
39. Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480.
Butler SJ; Richardson L; Farias N; Morrison J; Coomber BL
Biochem Biophys Res Commun; 2017 Aug; 490(1):29-35. PubMed ID: 28576498
[TBL] [Abstract][Full Text] [Related]
40. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]